A spacer device was modified to deliver aerosols of beclomethasone diproprionate, ipratropium and bromide salbutamol, to an asthmatic child with a tracheostomy, where symptoms were poorly controlled with nebulized therapy. This resulted in a marked improvement in symptoms and a dramatic reduction in the time spent administering drugs.